Monogram Orthopedics

Monogram Orthopedics

Growth Stage

Future of Joint Reconstruction.

Overview

Raised this Round: Raised: $4,599,145

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

07/14/2022

Close Date

03/16/2023

Min. Goal
$100,000
Max. Goal
$5,000,000
Min. Investment

$500

Security Type

Equity - Preferred

Series

Series B

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$10.01

Pre-Money Valuation

$155,000,000

Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B2C

Margin

Low

Capital Intensity

High

Location

Austin, Texas

Business Type

Growth

Monogram Orthopedics, with a valuation of $155 million, is raising funds on DealMaker Securities. The company is developing a product solution architecture to allow the personalization of orthopedic implants. Monogram Orthopaedics uses 3D printing and robotics through automated digital image analysis algorithms. The Monogram Knee System has won FDA approval and is solving real problems by revolutionizing joint replacement technology. Dr. Douglas Unis founded Monogram Orthopaedics in 2016. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $5,000,000. The campaign proceeds will be used for research and development.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$628,246

$0

COGS

$458,675

$0

Tax

$0

$0

 

 

Net Income

$-11,814,968

$-9,068,006

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$5,535,710

$5,586,748

Accounts Receivable

$0

$0

Total Assets

$8,715,366

$8,115,888

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 07/14/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Monogram Orthopedics 05/22/2023 Dealmaker Securities $246,000,000 $15,958,364 Equity - Common Funded RegA+
Monogram Orthopedics 04/27/2023 Republic $246,000,000 $233,363 Equity - Common Funded RegA+
Monogram Orthopedics 03/15/2023 Dealmaker Securities $155,000,000 $4,599,145 Equity - Preferred Funded RegCF
Monogram Orthopaedics 02/17/2022 StartEngine $89,000,000 $23,648,853 Equity - Preferred Funded RegA+
Monogram Orthopaedics 01/15/2021 StartEngine $89,900,000 $2,965,501 Equity - Preferred Funded Test the Waters / RegA+
Monogram Orthopaedics 03/30/2020 SeedInvest $21,250,000 $14,588,668 Equity - Preferred Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Higher precision and faster surgeries. That’s the name of the game with Monogram.

At first glance, this may seem too futuristic (and borderline impossible).  

I’m here to tell you that Monogram has nearly done it. The company is conducting live surgical demonstrations of its robot for the orthopedic community and is gearing up for FDA submission.  

Once the company’s robot is approved by the FDA, Monogram will launch its first-generation knee offering with generic implants. Once this has been successfully rolled out to hospitals, the company will release its second generation of implants: 3D-printed implants that closely match a patient’s anatomy and stand to disrupt this space in a major way.  

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Monogram Orthopedics on DealMaker Securities 2022
Platform: Dealmaker Securities
Security Type: Equity - Preferred
Valuation: $155,000,000
Price per Share: $10.01

Follow company

Follow Monogram Orthopedics on DealMaker Securities 2022

Buy Monogram Orthopedics's Deal Report

Warning: according to the close date for this deal, Monogram Orthopedics may no longer be accepting investments.

Monogram Orthopedics Deal Report

Get KingsCrowd’s comprehensive report on Monogram Orthopedics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Monogram Orthopedics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Monogram Orthopedics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge